Research Article
IDH Mutations: Genotype-Phenotype Correlation and Prognostic Impact
Table 1
Patients demographics and clinical characteristics.
| | | Glioma by grade |
| | Characteristics | II
() | III
() | IV
() | | Age, years | | | | | Median | 38.1 | 47.8 | 58.5 | | Range | 16.1–77.0 | 19.1–89.1 | 18.2–89.1 | | KPS | | | | | Median | 90 | 90 | 80 | | Range | 50–100 | 60–100 | 40–100 | | Biopsy (%) | 25.6 | 28.7 | 26.6 | | Tumor removal (%) | 74.4 | 71.3 | 73.4 | | Overall survival, months | | | | | Median | 121.9 | 41.7 | 14.5 | | Range | 0.1–238.9 | 0.1–249.3 | 0.1–89.1 | | Progression free survival, months | | | | | Median | 38.8 | 19.5 | 8.2 | | Range | 0.1–189.7 | 0.1–249.3 | 0.1–80.5 |
|
|
KPS: Karnofsky performance score; PFS: progression-free survival.
|
